The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000-2009
{{output}}
Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at death) and medical expenditure in France during the period 2000-2009. The estimates imply that pharmaceutical innovation increased mean age a... ...
